Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for RHEP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
March 31, 2026 -5.77%
December 31, 2025 12.99%
September 30, 2025 22.34%
June 30, 2025 -14.41%
March 31, 2025 -17.30%
December 31, 2024 -10.04%
September 30, 2024 -23.24%
June 30, 2024 -16.32%
March 31, 2024 -23.31%
December 31, 2023 -5.26%
September 30, 2023 -23.51%
June 30, 2023 -14.90%
March 31, 2023 -51.00%
December 31, 2022 -22.10%
September 30, 2022 -3.36%
June 30, 2022 -16.37%
March 31, 2022 -44.03%
December 31, 2021 -10.27%
September 30, 2021 -0.58%
June 30, 2021 -7.78%
March 31, 2021 0.30%
December 31, 2020 -25.83%
September 30, 2020 -1.49%
June 30, 2020 8.94%
March 31, 2020 0.51%
Date Value
December 31, 2019 11.64%
September 30, 2019
June 30, 2019 -25.43%
March 31, 2019 0.11%
December 31, 2018 -35.67%
September 30, 2018 -88.77%
June 30, 2018 -54.05%
March 31, 2018 -41.31%
December 31, 2017 5.39%
September 30, 2017 4.19%
June 30, 2017 9.90%
March 31, 2017 -8.79%
December 31, 2016
September 30, 2016 3.10%
June 30, 2016 -16.85%
March 31, 2016 -20.08%
December 31, 2015 -70.90%
September 30, 2015 -33.25%
June 30, 2015 -85.77%
March 31, 2015 -482.3%
December 31, 2014 -9.63%
September 30, 2014 -5.01%
June 30, 2014 -4.55%
March 31, 2014 -3.67%
December 31, 2013 -4.43%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Chemed Corp. 10.08%
The Ensign Group, Inc. 7.18%
National HealthCare Corp. 9.50%
Oncologix Tech, Inc. --
InnovAge Holding Corp. -11.88%